U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06393764) titled 'Cancer-related Venous Thromboembolic Disease - Cohort Study' on April 19.
Brief Summary: Venous thromboembolic disease (VTE) is a common (1/1000), potentially serious disease (10% mortality when the clinical presentation is that of pulmonary embolism (PE)). In cancer patients, the risk of developing VTE is high and constitutes a negative prognostic factor for cancer; the risk of bleeding is also increased. The study of VTE in the context of cancer is a major challenge, given the frequency of the association, the heterogeneity of the situations, the risk factors involved and the therapeutic issues in both curative and primary preventio...